Hu-Friedy, the world leader in dental instrument manufacturing and instrument reprocessing workflows, recently introduced HuFriedyGroup as the Dental Division of Cantel.
Antiresorptive therapies for individuals with osteoporosis include five principal classes of agents: bisphosphonates, estrogens, selective estrogen receptor modulators, calcitonin, and monoclonal antibodies, such as denosumab.
Prescription drug misuse—taking medication originally intended for therapeutic use in a manner other than prescribed—commonly takes the form of opioid, stimulant, and central nervous system depressant misuse. For decades, prescription…
The National Center for Dental Hygiene Research & Practice has issued a Call for Abstracts for presentation during the 5th Global Dental Hygiene Research Conference scheduled Sept. 24–26 at the Bethesdan Hotel in Maryland.
Working under a 5-year National Institutes of Health grant, researchers at the University of Washington School of Dentistry in Seattle are seeking to improve how oral health professionals measure pediatric patients’ pain.
Researchers have taken the drug aprepitant—which is approved by the United States Food and Drug Administration but previously failed in clinical trials for pain—and repackaged it using a novel, nano-based technology to deliver the drug into…